| Market Cap | 4.23B | P/E | 50.79 | EPS this Y | 10.60% | Ern Qtrly Grth | 36.40% |
| Income | 101.95M | Forward P/E | 23.02 | EPS next Y | 9.30% | 50D Avg Chg | -10.00% |
| Sales | 1.28B | PEG | 2.15 | EPS past 5Y | 20.96% | 200D Avg Chg | -1.00% |
| Dividend | N/A | Price/Book | 3.53 | EPS next 5Y | 10.77% | 52W High Chg | -14.00% |
| Recommedations | 1.90 | Quick Ratio | 4.23 | Shares Outstanding | 58.11M | 52W Low Chg | 40.00% |
| Insider Own | 2.44% | ROA | 4.25% | Shares Float | 56.71M | Beta | 0.91 |
| Inst Own | 102.46% | ROE | 8.45% | Shares Shorted/Prior | 2.06M/2.26M | Price | 73.65 |
| Gross Margin | 46.54% | Profit Margin | 7.94% | Avg. Volume | 300,525 | Target Price | 92.00 |
| Oper. Margin | 11.07% | Earnings Date | Jul 23 | Volume | 364,823 | Change | -0.57% |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
| Canaccord Genuity | Buy | May 1, 24 |
| Barrington Research | Outperform | May 1, 24 |
| Piper Sandler | Overweight | May 1, 24 |
| Needham | Buy | May 1, 24 |
| Barrington Research | Outperform | Apr 16, 24 |
| CL King | Buy | Apr 11, 24 |
| Needham | Buy | Apr 11, 24 |
| Oppenheimer | Outperform | Feb 29, 24 |
| Barrington Research | Outperform | Feb 29, 24 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Millner F. Ann | Director Director | Jan 22 | Sell | 80 | 20,000 | 1,600,000 | 29,960 | 01/24/24 |
| Millner F. Ann | Director Director | Jan 22 | Option | 34.4 | 20,000 | 688,000 | 49,960 | 01/24/24 |
| LAMPROPOULOS FRED P | PRESIDENT AND CEO PRESIDENT AND CEO | Aug 25 | Option | 28.2 | 206,000 | 5,809,200 | 12,888 | 08/29/23 |
| Peterson Neil | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Aug 22 | Sell | 67.91 | 8,000 | 543,280 | 08/23/23 | |
| Peterson Neil | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Aug 22 | Option | 28.2 | 8,000 | 225,600 | 8,000 | 08/23/23 |
| ANDERSON A SCOTT | Director Director | Aug 09 | Sell | 69.4 | 22,180 | 1,539,292 | 49,217 | 08/11/23 |
| ANDERSON A SCOTT | Director Director | Aug 09 | Option | 50.5 | 25,000 | 1,262,500 | 71,397 | 08/11/23 |
| Voigt Michel James | CHIEF HUMAN RESOURCE.. CHIEF HUMAN RESOURCES OFFICER | Mar 14 | Sell | 68.31 | 2,000 | 136,620 | 515 | 03/15/23 |
| Ward Lynne | Director Director | Mar 08 | Option | 34.46 | 2,000 | 68,920 | 17,549 | 03/10/23 |
| Ward Lynne | Director Director | Mar 08 | Sell | 66.71 | 11,585 | 772,835 | 5,964 | 03/10/23 |
| ANDERSON A SCOTT | Director Director | Mar 06 | Sell | 66.74 | 15,000 | 1,001,100 | 47,135 | 03/08/23 |
| ANDERSON A SCOTT | Director Director | Mar 06 | Option | 26.6 | 15,000 | 399,000 | 62,135 | 03/08/23 |
| LAMPROPOULOS FRED P | PRESIDENT AND CEO PRESIDENT AND CEO | Feb 28 | Sell | 70.02 | 20,659 | 1,446,543 | 992,893 | 03/02/23 |
| Wright Joseph | CHIEF COMMERCIAL OFF.. CHIEF COMMERCIAL OFFICER | Nov 07 | Option | 16.05 | 15,000 | 240,750 | 32,031 | 11/09/22 |
| Parra Raul Jr. | CFO AND TREASURER CFO AND TREASURER | Aug 12 | Option | 28.2 | 2,000 | 56,400 | 9,031 | 08/16/22 |
| Parra Raul Jr. | CFO AND TREASURER CFO AND TREASURER | Aug 12 | Sell | 62.72 | 2,343 | 146,953 | 6,688 | 08/16/22 |
| Lloyd Brian G. | CHIEF LEGAL OFFICER,.. CHIEF LEGAL OFFICER, SECRETARY | Aug 11 | Option | 28.2 | 30,000 | 846,000 | 12,087 | 08/15/22 |
| Lloyd Brian G. | CHIEF LEGAL OFFICER,.. CHIEF LEGAL OFFICER, SECRETARY | Aug 11 | Sell | 62.02 | 26,900 | 1,668,338 | 11,994 | 08/15/22 |
| LAMPROPOULOS FRED P | PRESIDENT AND CEO PRESIDENT AND CEO | Aug 10 | Option | 16.05 | 56,000 | 898,800 | 9,859 | 08/12/22 |
| Frost Ronald | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Aug 10 | Option | 16.05 | 20,000 | 321,000 | 35,144 | 08/12/22 |
| Frost Ronald | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Aug 10 | Sell | 62.1 | 20,000 | 1,242,000 | 15,144 | 08/12/22 |
| Peterson Neil | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Aug 01 | Option | 16.05 | 4,000 | 64,200 | 4,000 | 08/03/22 |
| Peterson Neil | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Aug 01 | Sell | 58.1 | 4,000 | 232,400 | 08/03/22 | |
| Millner F. Ann | Director Director | Jun 03 | Option | 18.8 | 10,000 | 188,000 | 34,076 | 06/07/22 |
| Millner F. Ann | Director Director | Jun 03 | Sell | 61.92 | 6,378 | 394,926 | 27,698 | 06/07/22 |
| Wright Joseph | PRESIDENT, INTERNATI.. PRESIDENT, INTERNATIONAL | Sep 17 | Sell | 72.01 | 10,000 | 720,100 | 12,343 | 09/17/21 |
| Wright Joseph | PRESIDENT, INTERNATI.. PRESIDENT, INTERNATIONAL | Sep 17 | Option | 17.27 | 10,000 | 172,700 | 22,343 | 09/17/21 |
| Ward Lynne | Director Director | Sep 17 | Option | 34.46 | 14,867 | 512,317 | 21,969 | 09/17/21 |
| Ward Lynne | Director Director | Sep 17 | Sell | 71.83 | 9,470 | 680,230 | 12,499 | 09/17/21 |
| Lloyd Brian G. | CHIEF LEGAL OFFICER,.. CHIEF LEGAL OFFICER, SECRETARY | Sep 16 | Sell | 71.82 | 19,000 | 1,364,580 | 6,696 | 09/16/21 |
| Lloyd Brian G. | CHIEF LEGAL OFFICER,.. CHIEF LEGAL OFFICER, SECRETARY | Sep 16 | Option | 28.2 | 20,000 | 564,000 | 22,242 | 09/16/21 |
| LAMPROPOULOS FRED P | PRESIDENT AND CEO PRESIDENT AND CEO | Sep 10 | Option | 17.27 | 5,000 | 86,350 | 6,269 | 09/10/21 |
| Parra Raul Jr. | CFO AND TREASURER CFO AND TREASURER | Sep 10 | Sell | 72.01 | 4,000 | 288,040 | 2,343 | 09/10/21 |
| Parra Raul Jr. | CFO AND TREASURER CFO AND TREASURER | Sep 10 | Option | 44.8 | 4,000 | 179,200 | 4,343 | 09/10/21 |
| Frost Ronald | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Jun 16 | Option | 17.27 | 20,000 | 345,400 | 22,343 | 06/16/21 |
| Wright Joseph | PRESIDENT, INTERNATI.. PRESIDENT, INTERNATIONAL | May 24 | Option | 12.06 | 15,000 | 180,900 | 27,343 | 05/24/21 |
| Wright Joseph | PRESIDENT, INTERNATI.. PRESIDENT, INTERNATIONAL | May 24 | Sell | 62.03 | 15,000 | 930,450 | 12,343 | 05/24/21 |